Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|February 1, 1994
Peripheral blood stem cell collection using the small volume collection chamber in the Fenwal CS-3000 Plus blood cell separatorC S Rosenfeld, H Cullis, T Tarosky, et al.
Bone Marrow Transplantation|January 1, 1991
The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous bone marrow transplantationJ J Nemunaitis, J W Singer, J E Sanders
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1991
Allogeneic bone marrow transplantation for patients with hematologic malignanciesC D Buckner, C Anasetti, J Bianco, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cellsD F Andrews, J J Nemunaitis, J W Singer
Cancer Investigation|May 8, 2001
Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanomaJ Nemunaitis, T Fong, P Shabe, et al.
Molecular and Cellular Biology|June 1, 1989
Effect of 5-azacytidine on gene expression in marrow stromal cellsD F Andrews, J Nemunaitis, C Tompkins, et al.
Bone Marrow Transplantation|January 1, 1994
Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trialsF G Schuening, J Nemunaitis, F R Appelbaum, et al.
Cancer Gene Therapy|August 29, 2009
Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical developmentD D Rao, N Senzer, M A Cleary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II studyC Rosenfeld, R Collins, L Piñeiro, et al.
American Journal of Clinical Oncology|October 22, 1998
Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expressionA Singh, A Tong, N Ognoskie, et al.
Pageof 17